304 related articles for article (PubMed ID: 20960504)
1. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
Simard EP; Pfeiffer RM; Engels EA
Cancer; 2011 Mar; 117(5):1089-96. PubMed ID: 20960504
[TBL] [Abstract][Full Text] [Related]
2. Trends in cancer risk among people with AIDS in the United States 1980-2002.
Engels EA; Pfeiffer RM; Goedert JJ; Virgo P; McNeel TS; Scoppa SM; Biggar RJ;
AIDS; 2006 Aug; 20(12):1645-54. PubMed ID: 16868446
[TBL] [Abstract][Full Text] [Related]
3. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of cancer risk late after AIDS onset in the United States.
Simard EP; Pfeiffer RM; Engels EA
Arch Intern Med; 2010 Aug; 170(15):1337-45. PubMed ID: 20696958
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
8. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
9. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
12. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
13. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
14. Long-term cancer risk among people diagnosed with AIDS during childhood.
Simard EP; Shiels MS; Bhatia K; Engels EA
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
[TBL] [Abstract][Full Text] [Related]
15. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
16. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
17. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
van Leeuwen MT; Vajdic CM; Middleton MG; McDonald AM; Law M; Kaldor JM; Grulich AE
AIDS; 2009 Oct; 23(16):2183-90. PubMed ID: 19734774
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
19. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
20. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
